XML 41 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-based compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense Recorded in Consolidated Statements of Operations

Stock-based compensation is classified as follows in the accompanying condensed consolidated statements of operations for the three months ended March 31, 2025 and 2024 (in thousands):

 

 

 

 

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Cost of revenues, genomics

 

$

1,035

 

 

$

 

Cost of revenues, data and services

 

 

611

 

 

 

 

Technology research and development

 

 

3,319

 

 

 

 

Research and development

 

 

1,982

 

 

 

 

Selling, general and administrative

 

 

16,027

 

 

 

 

Total stock-based compensation

 

$

22,974

 

 

$